Diagnostic Performance and Safety of <sup>18</sup> F-rhPSMA-7.3 Positron Emission Tomography in Men With Suspected Prostate Cancer Recurrence: Results From a Phase 3, Prospective, Multicenter Study (SPOTLIGHT)Ashesh B. Jani, Katherine Zukotynski, Przemyslaw Twardowski et al.|The Journal of Urology|2023Cited by 65
A Phase 1/2 multicenter trial of DKN-01 as monotherapy or in combination with docetaxel for the treatment of metastatic castration-resistant prostate cancer (mCRPC)David R. Wise, Kwok‐Kin Wong, Russell K. Pachynski et al.|Prostate Cancer and Prostatic Diseases|2024Cited by 9